Pfizer and BioNTech launch clinical study of Covid vaccine targeting omicron
January 25, 2022 at 06:45 AM EST
Pfizer CEO Albert Bourla has said the company will have the omicron vaccine ready by March.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|